Skip to main content
. 2019 Jan 28;15:e00495. doi: 10.1016/j.idcr.2019.e00495

Table 1.

Acinetobacter radioresistens clinical case descriptions.

Case Age (years) Sex Comorbid Conditions Source Treatment Outcome
Visca et al. [9] 32 F HIV (CD4 cell count 309/mm3; viral load, <80 copies/mL) Blood Ciprofloxacin 400 mg twice a day for 14 days Survived
Savov et al. [10] 85 M COPD CHF (NYHA functional class III-IV) Tracheobronchial Ceftriaxone 2 × 1 g and Gentamicin 80 mg Dieda
Brady et al. [11] 53 F Li-Fraumeni syndrome Blood Ampicillin-Sulbactamb Survived
60 M Chronic foot ulcer, DM, ESRD/HD Blood Cefepimeb Survived
Our Patient 87 F Adenocarcinoma of lung Blood; Tracheal; Bronchial Ampicillin-Sulbactam 3 g every 6 hours Died

Abbreviations: CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; ESRD/HD, end-stage renal disease/hemodialysis; F, female; M, male; NYHA, New York Heart Association.

a

Unclear if A. radioresistens was the etiologic agent of infection.

b

Dosing information not provided.